Stanford L. Peng, MD, PhD
Dr. Peng received his undergraduate degrees from Stanford University and completed medical and graduate studies at the Yale University School of Medicine, followed by internal medicine residency at the Hospital of the University of Pennsylvania and rheumatology fellowship at Brigham and Women’s Hospital. After serving as Assistant Professor of Internal Medicine and Pathology and Immunology at Washington University in St. Louis, he held Senior Director positions at Roche Pharmaceuticals and ARYx Therapeutics. He joined Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason in early 2009.
Areas of Research
Clinical and/or translational research in rheumatic diseases.
Aud D, Peng SL. Transcription factors in inflammatory arthritis. Nature Clin. Pract. Rheumatol. 2: 434-442 (2006)
Peng SL. Foxo in the immune system. Oncogene 27: 2337-2344 (2008)
Peng SL, Craft J. Antinuclear Antibodies (Chapter 50). In Firestein GS, Budd RC, Harris ED, McInnes IB, Ruddy S, Sergent JS (Eds.) Kelly’s Textbook of Rheumatology, 8th Edition. Elsevier Inc, Philadelphia, PA (2008)
Peng SL. Altered T and B lymphocyte signaling pathways in lupus. Autoimmun Rev 8: 179-183 (2009)